Safety and Efficacy Study of Leuprolide Acetate for Injectable Suspension 22.5 MG in the Treatment of Prostate Cancer
Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to demonstrate the safety and efficacy of Leuprolide Acetate for
Injectable Suspension 22.5 mg in reducing serum testosterone to castrate levels in patients
with prostate cancer.